National Cancer Centre Singapore:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Cancer Centre Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9353
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Cancer Centre Singapore (NCCS) is a cancer research centre that offers research, education, clinical services, and patient care services. The centre offers services such as medical oncology, oncologic imaging, palliative medicine, pharmacy, psychosocial oncology, public education, radiation oncology and surgical oncology. It also offers training, upgrade and refresher courses in oncology. NCCS provide clinical trials, research, patient care, education services. The centre also offers research facility including genetic microarray system, flow cytometry, confocal microscopy, DNA sequencing and animal holding rooms, among others. It also provides training programs for oncologists, researchers, clinician scientists and health professionals. NCCS is headquartered in Singapore.

National Cancer Centre Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Centre Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Centre Singapore, Medical Devices Deals, 2012 to YTD 2018 9
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AUM Biosciences Enters into Partnership with National Cancer Centre Singapore 11
immunoSCAPE to Enter into Agreement with National Cancer Centre 12
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 13
Aslan Pharma Enters into MoU with National Cancer Centre Singapore 14
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 15
National Cancer Centre Singapore – Key Competitors 16
National Cancer Centre Singapore – Key Employees 17
National Cancer Centre Singapore – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Government and Public Interest 19
Mar 02, 2018: Customising liver cancer treatment 19
Mar 16, 2017: Doctors a step closer to giving liver cancer patients a more precise treatment 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Key Facts 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Centre Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Centre Singapore, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Centre Singapore, Medical Devices Deals, 2012 to YTD 2018 9
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AUM Biosciences Enters into Partnership with National Cancer Centre Singapore 11
immunoSCAPE to Enter into Agreement with National Cancer Centre 12
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 13
Aslan Pharma Enters into MoU with National Cancer Centre Singapore 14
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 15
National Cancer Centre Singapore, Key Competitors 16
National Cancer Centre Singapore, Key Employees 17

List of Figures
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cancer Centre Singapore, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[National Cancer Centre Singapore:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • Electricity Generation Company of Bangladesh Ltd:企業の戦略的SWOT分析
    Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), formerly Lijun International Pharmaceutical (Holding) Co Ltd is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bot …
  • Rogers Corp (ROG):企業の財務・戦略的SWOT分析
    Summary Rogers Corp (Rogers) is a diversified company. The company offers advanced connectivity solutions, elastomeric solutions, power electronic solutions and performance materials. Its advanced connectivity solutions include laminates, bond ply or prepreg, copper clad laminates and conductive adh …
  • Mediware Information Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • VolitionRX Ltd (VNRX):医療機器:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務分析
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ansell Limited (ANN):医療機器:M&Aディール及び事業提携情報
    Summary Ansell Limited (Ansell) is a provider of protection solutions. It develops, manufactures and markets a broad range of hand and arm protection solutions and hospital clothing. It also offers medical gloves and healthcare and industrial safety solutions. Ansell offers its products to healthcar …
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • Valbiotis SAS (ALVAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Valbiotis SAS (Valbiotis) is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, non-alcoholic steatohepatitis (NASH), obesity and cardiovascular diseases. The company ha …
  • Canada Bread Company, Limited:企業の戦略・SWOT・財務情報
    Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Canada Bread Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Decmil Group Ltd (DCG):企業の財務・戦略的SWOT分析
    Summary Decmil Group Ltd (Decmil), is a provider of construction, engineering and accommodation and project management services. The company provides services such as design, accommodation services, civil engineering, construction, and maintenance services, among others. Decmil provides government i …
  • Crown Bioscience Inc (6554):製薬・医療:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Immunovia AB (IMMNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • PT Gudang Garam Tbk:企業の戦略・SWOT・財務情報
    PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆